High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.
about
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsCladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies.A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis.A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma.Defining a novel cis element in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA: role in transforming growth factor-beta 1 induced mRNA stabilizationB-chronic lymphocytic leukemia: practical aspects.Cladribine: not just another purine analogue?Detection and Identification of Hematologic Malignancies and Solid Tumors by an Electrochemical Technique.Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias.Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignanciesTreatment of relapsed or refractory chronic lymphocytic leukemia.Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
P2860
Q28371742-66AA5AE8-C514-44CD-969E-8EE64053459EQ33337294-65F8ABFB-6C3F-4A6C-900E-9D9A46D1F5B2Q33346607-EC2D1054-5A2A-499A-8BB7-78451C1CD5ABQ33406478-7647C540-E43C-4314-A456-DE73F4E377CCQ33490388-B7993FD4-790E-422B-BF7D-E8A08CDDE9A9Q33504540-B982064C-8827-481D-8BFC-4AE38228FF7AQ34747706-AC7667D3-CC89-4DA2-A85C-4D815B00FF25Q34803868-0DE5D10B-14A5-4183-A38A-0D803453C262Q34992373-B5580FA3-5F92-4A9D-B919-3B5920CDB3D8Q35999322-467C1576-5926-4AF9-89DB-B5A63693EDDCQ36115780-2FCD63BC-ACB6-424C-B1AB-3BEE13870FDAQ36617540-4FFC558E-BF03-4A28-A3D4-D1D715033CCEQ37964916-69CCA559-CF01-488F-9C39-03165841E899Q48085869-0E362F27-CC97-41FF-AFD7-60AF3E7963C4
P2860
High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
High complete remission rate f ...... ase of blood lymphocyte count.
@ast
High complete remission rate f ...... ase of blood lymphocyte count.
@en
type
label
High complete remission rate f ...... ase of blood lymphocyte count.
@ast
High complete remission rate f ...... ase of blood lymphocyte count.
@en
prefLabel
High complete remission rate f ...... ase of blood lymphocyte count.
@ast
High complete remission rate f ...... ase of blood lymphocyte count.
@en
P1476
High complete remission rate f ...... ase of blood lymphocyte count.
@en
P2093
G Juliusson
J Liliemark
P304
P356
10.1200/JCO.1993.11.4.679
P407
P577
1993-04-01T00:00:00Z